Pulmatrix (PULM) Prepaid Assets (2014 - 2026)
Pulmatrix (PULM) posted Prepaid Assets of $120000.0 for Q1 2026, up 3900.0% sequentially from $3000.0 in Q4 2025, and down 62.15% YoY from $317000.0 in Q1 2025.
Pulmatrix (PULM) Prepaid Assets (2014 - 2026) Analysis & Trends
Pulmatrix has reported Prepaid Assets for 13 years, with the latest figure at $120000.0 in Q1 2026.
- Quarterly Prepaid Assets fell 62.15% year-over-year to $120000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $120000.0 (down 62.15% YoY) and the FY2025 annual result came in at $3000.0, down 98.33% from the prior year.
- Prepaid Assets advanced to $120000.0 in Q1 2026 per PULM's latest filing, from $3000.0 in the prior quarter.
- Over five years, Prepaid Assets peaked at $1.2 million in Q2 2024 and troughed at $3000.0 in Q4 2025.
- A 5-year average of $357117.6 and a median of $228000.0 in 2025 frame the typical range for Prepaid Assets.
- The sharpest annual moves came in 2023 and 2025: Prepaid Assets jumped 282.08% in 2023, then plunged 98.33% in 2025.
- Over 5 years, Prepaid Assets stood at $1.1 million in 2022, then plunged by 30.52% to $742000.0 in 2023, then sank by 75.74% to $180000.0 in 2024, then slumped by 98.33% to $3000.0 in 2025, then soared by 3900.0% to $120000.0 in 2026.
- According to Business Quant data, Prepaid Assets over the past three periods registered $120000.0, $3000.0, and $178000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Pulmatrix | 5.46 Mn | 5.46 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 371,000.00 |
| Mar 31, 2026 | 120,000.00 |
| Dec 31, 2025 | 3,000.00 |
| Sep 30, 2025 | 178,000.00 |
| Jun 30, 2025 | 228,000.00 |
| Mar 31, 2025 | 317,000.00 |
| Dec 31, 2024 | 180,000.00 |
| Sep 30, 2024 | 317,000.00 |
| Jun 30, 2024 | 1.20 Mn |
| Mar 31, 2024 | 134,000.00 |
| Dec 31, 2023 | 742,000.00 |
| Sep 30, 2023 | 405,000.00 |
| Jun 30, 2023 | 496,000.00 |
| Mar 31, 2023 | 294,000.00 |
| Dec 31, 2022 | 1.07 Mn |
| Sep 30, 2022 | 106,000.00 |
| Jun 30, 2022 | 135,000.00 |
| Mar 31, 2022 | 147,000.00 |
| Dec 31, 2021 | 316,000.00 |
| Sep 30, 2021 | 938,000.00 |